<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet type='text/xsl' href='https://www.aims-2-trials.eu/wp-content/plugins/google-sitemap-generator/sitemap.xsl'?><!-- sitemap-generator-url='http://www.arnebrachhold.de' sitemap-generator-version='4.1.23' -->
<!-- generated-on='April 14, 2026 4:33 pm' -->
<urlset xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd' xmlns='http://www.sitemaps.org/schemas/sitemap/0.9'>	<url>
		<loc>https://www.aims-2-trials.eu/privacy-policy/</loc>
		<lastmod>2022-06-21T10:11:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/imprint-disclaimer/</loc>
		<lastmod>2022-06-21T10:11:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/aims-2-trials-press-release/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/copyright/</loc>
		<lastmod>2022-06-21T10:11:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/contact/</loc>
		<lastmod>2026-01-20T10:24:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/</loc>
		<lastmod>2026-02-23T13:54:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/kings-college-london/</loc>
		<lastmod>2025-08-20T14:33:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/old-research/clinical-network/</loc>
		<lastmod>2020-11-10T12:06:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/autism-representatives/</loc>
		<lastmod>2026-03-31T14:59:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/roche/</loc>
		<lastmod>2025-08-20T15:04:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-cambridge/</loc>
		<lastmod>2025-08-20T13:16:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-groningen/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-oxford/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/inserm/</loc>
		<lastmod>2023-09-05T13:20:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-edinburgh/</loc>
		<lastmod>2026-02-23T13:59:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/public-hospitals-paris/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/trinity-college-dublin/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-london-birkbeck/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/ecnp/</loc>
		<lastmod>2022-09-01T09:36:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/noldus/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/arttic-2/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/karolinska-institute/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/demcon/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/goethe-university-frankfurt/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/umc-utrecht/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/ghent-university/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-ulm/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-hospitals-of-tours/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/technical-university-munich/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/stella-maris-foundation/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-salamanca/</loc>
		<lastmod>2020-12-09T11:28:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-glasgow/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/cea/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-medical-centre-gottingen/</loc>
		<lastmod>2024-12-06T10:30:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/stellenbosch-university/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/uppsala-university/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-coimbra/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/policlinica-gipuzkoa-foundation/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/clinical-foundation-biomedical-research/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/janssen/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/radboudumc/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/novartis/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/ucb-biopharma/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/teva/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/autism-speaks/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/simons-foundation/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/autistica/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/autism-europe/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-bristol/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/starlab/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/health-services-of-madrid/</loc>
		<lastmod>2024-09-19T15:16:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/institut-pasteur/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-basel/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/central-institute-of-mental-health/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/biosci-consulting/</loc>
		<lastmod>2020-11-05T07:54:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/publications/educational-center/</loc>
		<lastmod>2019-02-18T16:14:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/team/university-of-newcastle/</loc>
		<lastmod>2020-11-05T07:54:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/faqs/</loc>
		<lastmod>2025-06-26T14:41:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/news/publications_old/</loc>
		<lastmod>2021-04-15T09:12:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/news/</loc>
		<lastmod>2026-03-18T14:17:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/old-research/ethics/</loc>
		<lastmod>2020-11-05T08:02:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/home/autism-community/</loc>
		<lastmod>2019-02-18T16:14:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/testing-new-medicines/</loc>
		<lastmod>2026-03-03T13:38:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/</loc>
		<lastmod>2025-07-22T11:55:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/data-management-analysis/</loc>
		<lastmod>2025-08-20T15:32:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/autism-policy-across-europe/</loc>
		<lastmod>2026-03-13T11:00:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/ethics/</loc>
		<lastmod>2025-08-20T15:58:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/funding/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/language/</loc>
		<lastmod>2025-08-21T12:11:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/autism-community/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/clinical-trials-network/</loc>
		<lastmod>2026-01-16T14:35:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/project-management/</loc>
		<lastmod>2025-08-20T15:08:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/communication/</loc>
		<lastmod>2019-02-25T10:11:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers_old/epilepsy-development-study/</loc>
		<lastmod>2020-01-16T14:37:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/influence-early-environment/</loc>
		<lastmod>2020-08-11T11:27:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers_old/brain-development-babies-study/</loc>
		<lastmod>2020-01-16T14:37:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/brain-behaviours-early-life/</loc>
		<lastmod>2020-11-18T12:46:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/outcome-measures/</loc>
		<lastmod>2020-08-11T11:28:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/rare-genetic-conditions/</loc>
		<lastmod>2020-08-11T11:28:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/testing-new-medicines/serotonin-studies/</loc>
		<lastmod>2019-11-05T13:20:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/testing-new-medicines/gaba-studies/</loc>
		<lastmod>2021-06-21T15:51:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/testing-new-medicines/medicine-social-difficulties/</loc>
		<lastmod>2026-02-10T10:14:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/how-you-benefit/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/beyond-medicines/</loc>
		<lastmod>2019-03-25T15:30:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/aims-2-trials-press-release-2/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/</loc>
		<lastmod>2026-01-27T10:39:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/how-to-get-involved/</loc>
		<lastmod>2025-08-20T13:08:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/pip-radboud/</loc>
		<lastmod>2023-05-09T15:18:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/pip-karolinska/</loc>
		<lastmod>2022-06-21T10:11:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/pip-at-ghent/</loc>
		<lastmod>2022-06-21T10:11:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/pip-at-paris/</loc>
		<lastmod>2022-06-21T10:11:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/pip/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/newsletter-1/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/news/publications/</loc>
		<lastmod>2026-03-10T12:04:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/pip-meet-the-production-team/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/eu-aims/</loc>
		<lastmod>2020-05-28T09:34:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/behaviour-and-cognition/repetition-and-inflexibility/</loc>
		<lastmod>2020-06-30T13:58:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/behaviour-and-cognition/social-interaction-and-rewards/</loc>
		<lastmod>2020-06-30T13:57:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/behaviour-and-cognition/sensory-processing/</loc>
		<lastmod>2020-06-30T14:02:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/behaviour-and-cognition/</loc>
		<lastmod>2020-06-30T14:06:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/infection-and-inflammation-during-pregnancy/</loc>
		<lastmod>2020-06-30T14:00:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/biomarkers/immune_system/</loc>
		<lastmod>2020-06-30T14:00:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/leap-front-page/</loc>
		<lastmod>2026-03-27T11:36:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/about-aims-2-trials/imireporting/</loc>
		<lastmod>2020-12-14T16:34:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/pip-kcl-2/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-research/autism-policy-across-europe/our-policy-related-studies/</loc>
		<lastmod>2021-02-03T10:34:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-slovenian/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-french/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-italian/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-german/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-spanish/</loc>
		<lastmod>2022-06-21T10:11:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/newsletter2/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-english/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-czech/</loc>
		<lastmod>2024-04-12T12:42:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/policy-study-resources-polish/</loc>
		<lastmod>2022-06-21T10:11:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/autism-community/resources/</loc>
		<lastmod>2026-02-25T10:19:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/our-working-groups/</loc>
		<lastmod>2026-04-07T16:09:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/additional-resources/</loc>
		<lastmod>2024-04-15T13:36:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
</urlset><!-- Request ID: 1334405cdfb6a2b94a61af11b5709550; Queries for sitemap: 19; Total queries: 95; Seconds: 0.03; Memory for sitemap: 1KB; Total memory: 117MB -->
